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INTRODUCTION
The understanding of the role of bone marrow micro-
environment in human hematopoiesis has been ham-
pered due to lack of a good animal model. Several ap-
proaches have been used to develop an animal model of
human hematopoiesis including the engraftment of hu-
man hematopoietic cells into severe combined immuno-
deficient (SCID) mice (5-7,10,16). But by using adult
and fetal hematopoietic cells only a limited degree of
human hematopoiesis was observed (8). There may be
at least two explanations for this. First, the residual non-
specific immune system of SCID mice (NK cells and
macrophages) may be a barrier to the survival of hema-
topoietic cells (9) in the mouse and, second, the human
hematopoietic microenvironment may be required for
efficient human hematopoiesis.
The effect of human hematopoietic microenviron-
ment on hematopoiesis has been investigated in SCID
mice. Human fetal bone was implanted into SCID mice.
Fetal bone maffow cells were detected in the implanted
bone and a small number of circulating human CD45-
cells were found in the mouse blood but no data were
provided on the infiltration of hematopoietic cells in
other mouse tissues (7). Morever, this approach has lim-
itations. Fetal tissues do not reflect adult hematopoietic
conditions (13,14). Heike et al. (3) implanted adult bone
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in SCID mice and also administered human cytokines at
the site of bone implantation and detected circulating
human cells in SCID mice only for the duration of cyto-
kine administration. Implantation of adult bone in the
absence of cytokine administration has failed (3). How-
ever, the regular administration of cytokines may skew
the differentiation of human bone marrow cell pop-
ulations.
Several approaches have been tried to overcome the
SCID mouse immune barrier to human hematopoietic
cells. The frrst one was to implant adult human bone in
SCID mice pretreated with radiation and anti-asialo
GMI rabbit sera (13), which showed clearly that the
main barrier to the successful implantation of viable hu-
man tissues in SCID mice is host macrophages and NK
cells. An altemative is to implant human bone fragments
into nonobese diabetes (NOD/SCID) mice, which are to-
tally immunodeficient (1a). Fujiki et al. implanted (2)
human rib fragments in NOD/SCID and described a
dominant expansion of human T lymphocytes in periph-
eral blood and fatty degeneration of marrow in the im-
planted bone fragments by 8 weeks. This approach also
has some limitations. The human bones were obtained
from lung cancer patients wherein the bone marrow
could present reactive changes in response to the pathol-
ogy and/or the treatment. In our hypothesis, NOD/SCID
mice would be better recipients for human bone marrow
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than SCID mice. No pretreatment is necessary to deplete
residual NK cells and macrophages of SCID mice and
we postulate that adult bone marrow fragment contain-
ing an intact hematopoietic microenvironment would
sustain human hematopoiesis for several weeks.
We thus implanted normal human bone fragments
into NOD/SCID mice and we looked for human hemato-
poiesis in these animals. The adult human bone fragment
implanted was viable and functional at 9 weeks post-
transplant and human hematopoiesis was maintained for
12 weeks.
MATERIALS AND METIIODS
Antibodies
Mouse IgG anti-human CD45 antibody (Becton Dick-
inson) conjugated with fluorescein isothiocyanate (FITC)
was used to detect pan-leucocytes of human origin.
Mouse IgM anti-human p2-microglobulin antibody
(Pharmingen) stains human cells that express HLA class
I antigen complex. Rabbit IgM anti-mouse conjugated
with biotin was used to reveal the p2-microglobulin
staining.
Rabbit IgG anti-human von Willebrand factor anti-
body (Dako) was used to identify the presence of blood
vessels. Goat IgG anti-rabbit conjugated with biotin
and peroxidase (Dakocytomation envision+- system la-
beled polymer-HRP) was used to reveal the von Vy'ille-
brand factor staining.
Reagents
Avidin-biotin-peroxidase was obtained from Vector,
diaminobenzidine (DAB) was purchased from Merck,
and bisbenzimide was from Sisma.
Mice
NOD/SCID mice were purchased from Jackson Lab-
oratories (Bar Harbor, ME) and were maintained under
specific pathogen-free conditions. Mice received nutri-
tional chow and water ad libitum and were used when
6-8 weeks old. The experimental work was conducted
according to the procedures outlined in the Law for Care
and Use of Laboratory Animals (Anêté Royal, Novem-
ber 14,1993, Belgium).
Origin of Human Bone
Cancellous bone was obtained from healthy volunteer
patients (age range 12-52 years) during hip surgery us-
ing protocols approved by the Human Ethics Commit-
tee. Cancellous bone was obtained from the posterior
iliac crest, minced in small fragments approximately 0.5
cm, and maintained under sterile conditions in RPMI-
1640 medium (Life Technologies).
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Implantation of NOD/SCID Mice With Human Bone
Transplantation of bone into NOD/SCID mice was
performed within 2 h of procurement, under a general
anesthesia (Forene, S.A. Abbot). Human bone fragments
were transplanted subcutaneously over the back of the
animal.
Tissue Processing for Histology and Preparation
for Flow Cytometic Analysis
At various time points (4, 6, 8, 9, 10, and 12 weeks),
mice were killed by CO2 inhalation. Three mice were
used for each endpoint. The human bone marrow was
removed and fixed in Histocon@ (Polysciences Inc.,
Warrington, PA), embedded in Tissue-Tek- (O.C.T.
compound), and frozen at 
-80"C.
The peripheral blood was taken from the retro-orbital
sinus; bone marrow and spleen were collected. These
tissues were teased apart and passed through a tissue
filter (Blutex, 60 pm) to remove debris. After lysis of
red blood cells with hypotonic saline solution (NHoCl,
KHCO3, and EDTA), white cells were incubated for 30
min at 4oC with a mouse anti-human CD45 antibody
(mouse IgG conjugated with FITC), titrated with refer-
ence cells and used at saturating concentrations, and an-
alyzed by flow cytometry. Cells were analyzed with a
FACStar plus (Becton Dickinson) equipped with an
argon neon laser. Specific fluorescence of FITC excited
at 488 nm as well as forward and orthogonal light scatter
signals were used to establish sort windows. Listmode
analysis was done by using the CellQuest program (Bec-
ton Dickinson). Listmode data were obtained from more
than 10,000 cells. Negative control consisted of addi-
tional aliquots of the same cells stained with irrelevant
isotype-matched control antibody directly labeled with
the identical fluorochrome. Positive control was human
blood cells incubated with mouse anti-human CD45 an-
tibody coupled to FITC. To separate human from mouse
cells on the basis of their size, dot plot analysis was
performed on human lymphocytes isolated from a buffy
coat and on a cell suspension from murine spleen. To
determine the threshold of detection of FACS analysis,
human lymphocytes incubated for 30 min at 4oC with a
mouse anti-human CD45 antibody conjugated with
FITC were serially diluted in nonstained lymphocytes
and the lowest percentage detected by flow cytometry
was evaluated.
Enzymology of Implanted Human Bone
For alkaline phosphatase activity detection, 5-pm
cryostat sections were incubated in a reaction medium
containing 1 mg ml-l fast blue BB salt, 0.3 mg ml-'
naphthol-AS-phosphate (both Sigma, Poole, UK), and
0.57o N,N-dimethylformamide in 0.2 M Tris buffer (pH
9.1). To reveal the chloroacetate esterase expression,
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specimens were incubated in a reaction medium contain-
ing 27o parafuchsin-hydrochloride (Fluka Chemie), 0.1
mg ml-' naphthol-ASD-chloroacetate (Sigma, Poole,
UK), and l7o N,N-dimethylformamide in 0.15 M Vero-
nal buffer (pH 6.3).
Histolo gy and Immunohistolo gy
of Implanted Human Bone
Endogenous peroxidase activity was inhibited by in-
cubating the sections for 10 min in 37o H2O2. Parallel
sections were incubated for 2 h at room temperature
with a mouse anti-human pr-microglobulin antibody ti-
trated with reference tissues and used at saturating con-
centrations, then with an anti-mouse IgM conjugated
with biotin, and finally with avidin-biotin-peroxidase.
After incubation in DAB, sections were counterstained
with hematoxylin and eosin (Surgipath), mounted with
entellan (Merck), and observed with a light microscope.
Positive cells were stained in brown. For von Willebrand
staining, endogenous peroxidase activity was also inhib-
ited as described above. Sections were incubated for 30
min at room temperature with a rabbit anti-human von
Willebrand antibody used at optimal dilutions, then with
an anti-rabbit IgG coupled with biotin and peroxidase
during 30 min. After incubation for 3 min in DAB, sec-
tions were counterstained with hematoxylin and eosin,
mounted with entellan, and observed with a light micro-
scope. Endothelial positive cells were stained in brown.
For immunofluorescence, sections were incubated
with a mouse anti-human CD45 antibody coupled with
FITC. Positive cells were green cells. Nuclei were coun-
terstained in blue with DAPI (bisbenzimide).
RESULTS
To develop an animal model for human hematopoie-
sis, we implanted fragments of healthy adult human
bone into NOD/SCID mice. A small fragment of poste-
rior iliac crest was subcutaneously implanted.
Human Hematopoiesis in hu-Bone NOD/SCID Mice
To detect the presence of human hematopoietic cells
in hu-bone NOD/SCID mouse tissues, blood, spleen,
and bone malrow of the animal retrieved at several time
points postimplantation (4, 6, 8, 9, 10, and 12 weeks)
were stained with a mouse anti-human CD45 antibody,
which is a marker for pan-leucocytes. To identify human
cells from mouse cells a scatter dot plot was used, which
distinguishes human cells from mouse cells on the basis
of their size (Fig. 1). The spikes indicate that murine
cells and human cells have clearly different sizes on the
basis of their SSC and FSC scatters.
To determine the threshold of detection of FACS
analysis, we mixed human lymphocytes stained with a
mouse anti-human CD45 antibody FITC with non-
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Figure 1. Identification of mouse (M) and human (H) cells in
a scatter dot plot. (A) Spleen cells from a mouse, (B) human
lymphocytes, (C) mouse and human cells are mixed in the
same suspension. The spikes corresponding to their respective
SCC and FSC scatters allows a clear distinction between both
types of cells.
stained lymphocytes. FACS analysis allows to detect
0.0lVo of positive cells (Fig. 2).
To characterize expression of CD45 on human blood
lymphocytes, three populations of cells are analyzed:
lymphocytes (L), monocytes (M), and granulocytes (G)
(Fig. 3). Eighty percent of human blood cells were
stained with anti-CD45 antibody with different fluores-
cent intensity: fluorescence of lymphocytes is at 10r, that
of granulocytes at 10r, and that of monocytes is at an
intermediate value.
Human cells, undetectable at 8 weeks posttransplant,
began to emerge at 9 weeks in the blood, the spleen, and
the bone marrow of some mice (Table 1). The results of
one representative experiment are illustrated in Figure
48 and D. The human cells constituted 0.657o of circu-
lating mononuclear cells and 0.237o of spleen mononu-
clear cells. At 12 weeks, the percentage of human cells
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Figure 2. CD45 expression on human lymphocyte. (A) Negative cells and (B, C) positive cells.
(B) 2.45Vo positive cells are present in the ceil suspension. (C) FACS anaiysis indicates as low as
0.017o oositive cells diluted in nesative ce1ls.
Figure 3. CD45 expression on human blood cells. Human blood cells were stained with CD45
antibody. The results indicate that 80Vo of these cells express this molecule: lymphocytes (L) at
103, monocytes (M) at 10'z, and granulocytes (G) at an intermediate value. *Negative control.
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Table 1. Presence of Human CD45- Cells in NOD/SCID Mouse Tissues (Blood, Spleen, and Bone Marrow)
at Several Time Points After Implantation
Weeks After Human Bone Graft
827
t2t0
Patient 1 blood: <0.17o
spleen: <0.17o
BM: <0.17o
Patient 2 nd
nd
nd
nd
nd
nd
blood: <0.17o
spleen: <0.17o
BM: <0.17o
blood: <0.17o
spleen: <0.17o
BM: <0.17c
blood: <0.17o
spleen: <0.17o
BM: <0.17o
blood: 0.657o
spleen: 0.23Vo
BM: <0.7Vo
nd
nd
nd
blood: 0.357o
spleen'.0.20Vo
BM: <0.7Vo
nd
nd
nd
nd
nd
nd
blood:0.107c
spleen: 0.107o
BM: <0.17o
found in mouse blood and spleen mononuclear cells was
0.17o. The fluorescence intensity of these cells corre-
sponds to that of lymphocytes.
H i s to lo gy and I mmuno hi s t o lo gy
of Implanted Human Bone
Immunohistological and histological analysis of adult
human bone implants in NOD/SCID mice was per-
formed at different times posttransplantation. By 9
weeks, human bone implant was viable, as shown in
Figure 5A. Active osteoblasts, osteocytes, and osteoid-
deposited surface were present near the new bone
formed (Fig. 5A). Numerous blood vessels identified by
an anti-von Willebrand factor antibody were observed
in the mouse tissue surrounding the bone implant (Fig.
5C). The human origin of these vessels was assessed
using an anti-human B2-microglobulin (specific for HLA
class I antigen complex) antibody, which also allows to
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Figure 4. CD45 expression in the (A) blood and (B) spleen of a NOD/SCID mouse 9 weeks after
human bone implantation. The blood contains O.65Vo of human leukocyte CD45- and the spleen
contains 0.23Vo of human CD45t cells. (A, C) Negative controls and (B, D) cells stained with anti-
human CD45 antibody.
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Figure 5. Histological and immunohistological analysis of human bone 9 weeks after transplantation in a NOD/SCID mouse.
Sections were stained with (A) hematoxylin and eosin, (B, E) anti-human B1-microglobulin, and (C) anti-von Willebrand factor.(D, F) Negative controls. Human viable bone and osteoid surface (arrow) are seen in (A). Hematopoietic foci are shown (arrow)
in human tissue in (B). Blood vessels are identified in murine tissues surrounding the graft (arrows) in (C), which are of human
origin (E).
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Figure 6. Immunofluorescence analysis of human bone 9 weeks after transplantation in a NOD/SCID mouse. CD45* cells can be
obser.red in green (A) and nuclei are colored in blue with DAPI (B).
demonstrate human hematopoietic foci (Fig. 5E and B).
Immunostaining with anti-CD45 antibodies revealed that
some cells of ihe hematopoietic foci observed in the hu-
man bone fragment express CD45 (Fig. 6A).
Enzymolog_v of Implanted Hwnan Bone
Enzymology analysis of adult human bone implants
in NOD/SCID mice was perfbrmed on cryostat sections.
By 9 weeks, cells of the myeloid lineage (colored in red)
were found in the human bone marrow (Fig. 7A); they
were sunounded by cytoplasmic processes of fibro-
blastic-like cells that expressed alkaline phosphatase
(Fie. 7B).
DISCUSSIOI{
Several reports on human hematopoiesis in SCID
mice, after implantation of either human fetal bone or
injection of fetal bone marrow cells, have been pub-
lished (6,7). However, embryonic and adult hemato-
poietic progenitors differ with respect to cycling rates,
responses profiles to hematopoietic factors, and differen-
tiation capacities (7). Others have reported about trans-
plantation of adult human bone into SCID mice. Heike
et al. (3) reported that human hematopoietic cells were
viable in SCID mice only when human cytokines were
administered at the site of bone implantation. Fujiki et
al. (2) transplanted adult human bone in NOD/SCID
mice and described dominant expansion of human T
cells with fatty degeneration of marrow in the implanted
bone fragment by 8 weeks.
In this report, we document the successful implanta-
tion of viable human bone into NOD/SCID mice. Osteo-
blastic cells survived and were functional up to at least
9 weeks as demonstrated bv osteoid deposit on the bone
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Figure 7. Enzymological analysis of human bone 9 weeks after transplantation in a NOD/SCID mouse. Chloroacetate esterases
(in red) are present in hematopoietic foci of the myeloid lineage (A, arrows). The are surrounded by cytoplasmic processes express-
ing alkaline phosphatase (in blue, B).
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surface. The reason for this discrepancy in bone viability
may result from the origin of transplanted bone. We im-
planted bone from the posterior iliac crest from healthy
patients rather than rib fragments from patients suffer-
ing from cancer, wherein bone marrow could be altered
by the pathology and/or treatment. Immunohistological
analysis of human bone graft demonstrated the presence
of human vessels in mouse tissues surrounding the trans-
planted human fragment. They probably ensure the mi-
gration of human blood cells from human bone marrow
to the mouse tissues: human CD45* cells were observed
in the transplanted bone fragment by 9 weeks. At 9
weeks, NOD/SCID-hu tissue cells were analyzed by
flow cytometry for human CD45'cells and showed that
0.657o and 0.23Vo of human cells are recovered in blood
and spleen, respectively, of the host animal. Human cells
were still present at 12 weeks. Clearly, human hemato-
poietic cells from the implanted bone fragment were
able to home and to persist in the murine tissues. During
the first 8 weeks, we did not find any human cells, but
that is not surprising. Previous studies (12) describe that
at 3 weeks posttransplantation human bone marrow un-
derwent a crisis phase due to poor vascularization of
the human graft and characterized histologically by a
rarefaction of bone marrow medullar cells. This aplasia
was transient, because the same authors demonstrated a
recovery of bone marrow by 12 weeks.
The number of human cells observed in the periph-
eral blood of the recipient was low. This can be ex-
plained by the reduced size of human fragment: we can
estimate the number of human stem cells engrafted at
about 24,000 per graft (1). The percentage of human
cells in the blood of the recipient is indeed directly pro-
portional to the quantity of human cells injected, so in
many experiences (4,11,15) several million were in-
jected. The full phenotype of human blood cells recov-
ered into NOD/SCID mice has not been analyzed. How-
ever, the fluorescence of CD45' cells corresponds to that
of lymphocytes. Moreover, some hematopoietic foci
observed in the implanted bone belong to the myeloid
lineage as assessed by the presence of chloroacetate es-
terases; they were surrounded by alkaline phosphatase-
positive fibroblastic-like cells resembling those de-
scribed by Western-Bayton (17). These observations
suggest that the implanted bone fragment sustains lym-
phopoiesis and granulopoiesis.
This model differs from those previously described:
we implanted only human bone rather than fetal bone;
we used no cytokines such as IL-3 or SCF; we did not
inhibit NK and macrophage functions with anti-asialo
GMl sera; we did not irradiate recipient mice befbre
transplantation. There are also differences in the mouse
strain used: NOD/SCID versus SCID. The results show
that this model is suitable ro analyze adult stromal-
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hematopoietic cell interactions in vivo. With further ef-
forts to refine the experimental protocol, it will be possi-
ble to extend use of this model to biopsies coming from
patients suffering from hematological malignancies.
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